Lansoprazole NDC 71335-9693

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-9693Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-9693Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-9693-1	71335969301	30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-9693-1)Marketed from Apr 18, 2023
71335-9693-2	71335969302	90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-9693-2)Marketed from Apr 18, 2023
71335-9693-3	71335969303	60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-9693-3)Marketed from Apr 18, 2023
71335-9693-4	71335969304	58 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-9693-4)Marketed from Apr 18, 2023
71335-9693-5	71335969305	28 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-9693-5)Marketed from Apr 18, 2023
71335-9693-6	71335969306	14 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-9693-6)Marketed from Apr 18, 2023
71335-9693-7	71335969307	120 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-9693-7)Marketed from Apr 18, 2023
71335-9693-8	71335969308	180 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71335-9693-8)Marketed from Apr 18, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lansoprazole
Generic name (nonproprietary): lansoprazole
Active ingredients: Lansoprazole — 15 mg/1
Dosage form: Capsule, Delayed release
Route: Oral
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203083
Marketing start: May 18, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Inhibition Gastric Acid Secretion (Physiologic effect)Proton Pump Inhibitors (Mechanism)
Identifiers: Product ID 71335-9693_7314235c-0007-4d48-a641-1866850b49ecSPL ID 7314235c-0007-4d48-a641-1866850b49ecSPL set ID 33fc642c-ad41-410b-9a81-eae456f3fcfbRxCUI 596843UNII 0K5C5T2QPG
Pharmacologic class: Proton Pump Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335969301 followed by a unit qualifier and the quantity

Package 71335-9693-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 18, 2023.

Indications (excerpt from the label)

Lansoprazole delayed-release capsules are proton pump inhibitor (PPIs) indicated for the: • Treatment of active duodenal ulcer in adults. ( 1.1 ) • Eradication of H. pylori to reduce the risk of duodenal ulcer recurrence in adults. ( 1.2 ) • Maintenance of healed duodenal ulcers in adults. ( 1.3 ) • Treatment of active benign gastric ulcer in adults. ( 1.4 ) • Healing of non-steroidal anti-inflammatory drugs (NSAID)-associated gastric ulcer in adults. ( 1.5 ) • Risk reduction of NSAID-associated gastric ulcer in adults. ( 1.6 ) • Treatment of symptomatic gastroesophageal reflux disease (GERD) in adults and pediatric patients 1 year of age and older. ( 1.7 ) • Treatment of erosive esophagitis…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 203083

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203083
Product	Strength	Form · route	Labeler	Product NDC
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	NuCare Pharmaceuticals,Inc.	68071-3634
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Camber Pharmaceuticals, Inc.	31722-570
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Camber Pharmaceuticals, Inc.	31722-571
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Bryant Ranch Prepack	71335-9680
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	NuCare Pharmaceuticals,Inc.	68071-2734
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Quallent Pharmaceuticals Health LLC	82009-039